Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Among patients with heart failure who have mitral regurgitation due to left ventricular dysfunction, the prognosis is poor. Transcatheter mitral-valve repair may improve their clinical outcomes. METHODS: At 78 sites in the United States and Canada, we enrolled patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy. Patients were randomly assigned to transcatheter mitral-valve repair plus medical therapy (device group) or medical therapy alone (control group). The primary effectiveness end point was all hospitalizations for heart failure within 24 months of follow-up. The primary safety end point was freedom from device-related complications at 12 months; the rate for this end point was compared with a prespecified objective performance goal of 88.0%. RESULTS: Of the 614 patients who were enrolled in the trial, 302 were assigned to the device group and 312 to the control group. The annualized rate of all hospitalizations for heart failure within 24 months was 35.8% per patient-year in the device group as compared with 67.9% per patient-year in the control group (hazard ratio, 0.53; 95% confidence interval [CI], 0.40 to 0.70; P<0.001). The rate of freedom from device-related complications at 12 months was 96.6% (lower 95% confidence limit, 94.8%; P<0.001 for comparison with the performance goal). Death from any cause within 24 months occurred in 29.1% of the patients in the device group as compared with 46.1% in the control group (hazard ratio, 0.62; 95% CI, 0.46 to 0.82; P<0.001). CONCLUSIONS: Among patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy, transcatheter mitral-valve repair resulted in a lower rate of hospitalization for heart failure and lower all-cause mortality within 24 months of follow-up than medical therapy alone. The rate of freedom from device-related complications exceeded a prespecified safety threshold. (Funded by Abbott; COAPT ClinicalTrials.gov number, NCT01626079 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The magnitude of the tirzepatide-mediated improvement in the win ratio was large and similar to the effect of transcatheter mitral valve repair in patients with HF and secondary mitral regurgitation.32”
From Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity (2025) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,044
Self-citation2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Self-citationPercutaneous Repair or Surgery for Mitral Regurgitation
Feldman, T., Foster, E., Glower, D. D., Kar, S., Rinaldi, M. J., Fail, P. S., Smalling, R. W., Siegel, R., Rose, G. A., Engeron, E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009355 · Cited by 2,183
Self-citationThe prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Goldstein, D., Moskowitz, A. J., Gelijns, A. C., Ailawadi, G., Parides, M. K., Perrault, L. P., Hung, J. W., Voisine, P., Dagenais, F., Gillinov, A. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512913 · Cited by 972
Self-citationPercutaneous Mitral Valve Interventions in the Real World
Maisano, F., Franzen, O., Baldus, S., Schäfer, U., Hausleiter, J., Butter, C., Ussia, G. P., Sievert, H., Richardt, G., Widder, J. D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.094 · Cited by 839
Stone, G. W., Adams, D. H., Abraham, W. T., Kappetein, A. P., Généreux, P., Vranckx, P., Mehran, R., Kuck, K.-H., Leon, M. B., Piazza, N., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.049 · Cited by 594
Self-citationSecondary Mitral Regurgitation in Heart Failure
Asgar, A. W., Mack, M. J., & Stone, G. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.009 · Cited by 489
Self-citation
Research works printed but not linked: 1
- 16. cancer events. Biostatistics 2007; 8: 70821.
Cited by
Items 301–400 of 1,001
Intraprocedural Residual Mitral Regurgitation and Survival After Transcatheter Edge-to-Edge Repair
Boekstegers, P., Hausleiter, J., Schmitz, T., Bufe, A., Comberg, T., Seyfarth, M., Frerker, C., Beucher, H., Rottländer, D., Higuchi, S., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.12.015 · Cited by 45
First-in-Human Implant of the Cephea Transseptal Mitral Valve Replacement System
Modine, T., Vahl, T. P., Khalique, O. K., Coisne, A., Vincent, F., Montaigne, D., Godart, F. R., BELLE, E. V., & Granada, J. F. (2019) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.119.008003 · Cited by 45
“The recent COAPT study (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation) showed a 2-year mortality benefit among congestive heart failure patients undergoing mitral edge-to-edge repair, especially among the patients in which the d…”
MethodPrognostic comparison of atrial and ventricular functional mitral regurgitation
Okamoto, C., Okada, A., Nishimura, K., Moriuchi, K., Amano, M., Takahama, H., Amaki, M., Hasegawa, T., Kanzaki, H., Fujita, T., et al. (2021) · Open Heart · doi:10.1136/openhrt-2021-001574 · Cited by 45
“While treatment strategies for V-FMR including optimal patient selection are starting to be reviewed, 25 26 outcome data of mitral valve intervention in A-FMR are very limited.”
Falasconi, G., Melillo, F., Pannone, L., Adamo, M., Ronco, F., Latib, A., Rahgozar, K., Carrabba, N., Valenti, R., Citro, R., et al. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29683 · Cited by 45
Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease
Grines, C. L., Klein, A. J., Bauser‐Heaton, H. D., Alkhouli, M. A., Katukuri, N., Aggarwal, V., Altin, S. E., Batchelor, W., Blankenship, J. C., Fakorede, F. A., et al. (2021) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29745 · Cited by 47
Heart–Brain Relationship in Stroke
Kelley, R. E., & Kelley, B. P. (2021) · Biomedicines · doi:10.3390/biomedicines9121835 · Cited by 45
Feng, K. Y., Ambrosy, A. P., Zhou, Z., Li, D., Kong, J., Zaroff, J. G., Mishell, J. M., Ku, I. A., Scotti, A., Coisne, A., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2809 · Cited by 44
Self-citationCerebral embolic protection during transcatheter heart interventions
Díaz, V. A. J., Kapadia, S. R., Linke, A. H.-P., Mylotte, D., Lansky, A. J., Grube, E., Settergren, M., & Puri, R. (2023) · EuroIntervention · doi:10.4244/eij-d-23-00166 · Cited by 44
“In the COAPT trial 54 , the stroke rate was 0.7% at 30 days, while in the MITRA-FR trial 55 , authors reported a periprocedural incidence of 1.4%.”
InfluentialSelf-citationCurrent status and future perspective of structural heart disease intervention
Tabata, N., Sinning, J., Kaikita, K., Tsujita, K., Nickenig, G., & Werner, N. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.02.022 · Cited by 44
Percutaneous Mitral Valve Interventions (Repair): Current Indications and Future Perspectives
Shah, M. K., & Jorde, U. P. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00088 · Cited by 44
“Chronic Secondary MR Two separate randomized controlled trials compared the efficacy of percutaneous MV repair using MitraClip to medical therapy among patients with significant secondaryMR and underlying LV abnormality [Table 5; (47, 48)].”
MethodRyu, R. J., & Tran, R. J. C. (2022) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296221103578 · Cited by 45
Higuchi, S., Orban, M., Adamo, M., Giannini, C., Melica, B., Karam, N., Praz, F., Kalbacher, D., Koell, B., Stolz, L., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2613 · Cited by 44
Self-citationAdvances in management of heart failure
Heidenreich, P. A., & Sandhu, A. T. (2024) · BMJ · doi:10.1136/bmj-2023-077025 · Cited by 44
“104 However, the MITRA-FR (Percutaneous Repair with the MitraClip Device for Severe Functional/Secondary Mitral Regurgitation) trial showed no reduction in mortality or hospital admission for heart failure with mitral valve TEER (304 patients; odds ratio 1.16, 0.73 to 1.84).”
MethodInfluentialTranscatheter Mitral Valve Replacement: State of the Art
Goode, D., Dhaliwal, R., & Mohammadi, H. (2020) · Cardiovascular Engineering and Technology · doi:10.1007/s13239-020-00460-4 · Cited by 43
Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation
Grayburn, P. A., Sannino, A., Cohen, D. J., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B. K., Rinaldi, M., Kapadia, S. R., Rajagopal, V., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.010 · Cited by 43
Self-citationInterventional heart failure therapy: A new concept fighting against heart failure
Saku, K., Yokota, S., Nishikawa, T., & Kinugawa, K. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.11.018 · Cited by 43
Vergaro, G., Gentile, F., Aimo, A., Januzzi, J. L., Richards, M., Lam, C. S. P., de Boer, R. A., Meems, L. M. G., Latini, R., Staszewsky, L. I., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13883 · Cited by 43
“51,52 In the present study, the optimal prognostic cut-offs of NT-proBNP were higher in women than in men.”
Asch, F. M., Little, S. H., Mackensen, G. B., Grayburn, P. A., Sorajja, P., Rinaldi, M., Maisano, F., & Kar, S. (2021) · EuroIntervention · doi:10.4244/eij-d-21-00012 · Cited by 42
Self-citationThe year in cardiology 2018: heart failure
Cleland, J. G. F., van Veldhuisen, D. J., & Ponikowski, P. P. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz010 · Cited by 42
Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR
Freitas‐Ferraz, A. B., Lerakis, S., Ribeiro, H. B., Gilard, M., Cavalcante, J. L., Makkar, R., Herrmann, H. C., Windecker, S., Enriquez-Sarano, M. L., Cheema, A. N., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.11.042 · Cited by 42
Park, S., Orban, M., Karam, N., Lubos, E., Kalbacher, D., Braun, D., Stolz, L., Neuß, M., Butter, C., Praz, F., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.12.042 · Cited by 42
Beohar, N., Ailawadi, G., Kotinkaduwa, L. N., Redfors, B., Simonato, M., Zhang, Z., Morgan, L. G., Escolar, E., Kar, S., Lim, D. S., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac026 · Cited by 42
Self-citationPagnesi, M., Adamo, M., Sama, I. E., Anker, S. D., Cleland, J. G. F., Dickstein, K., Filippatos, G. S., Inciardi, R. M., Lang, C. C., Lombardi, C., et al. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-01991-7 · Cited by 42
Yedidya, I., Lustosa, R. P., Fortuni, F., van der Bijl, P., Namazi, F., Vo, N. M., Meucci, M. C., Ajmone Marsan, N., Bax, J. J., & Delgado, V. (2021) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.120.012142 · Cited by 41
Sex-related similarities and differences in responses to heart failure therapies
Chyou, J. Y., Qin, H., Butler, J., Voors, A. A., & Lam, C. S. P. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-00996-1 · Cited by 41
Anker, S. D., Friede, T., von Bardeleben, R. S., Butler, J., Khan, M. S., Diek, M., Heinrich, J., Geyer, M., Placzek, M., Ferrari, R., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3286 · Cited by 41
Self-citationWerner, N., Puls, M., Baldus, S. E., Lubos, E., Bekeredjian, R., Sievert, H., Schöfer, J., Kück, K., Möllmann, H., Hehrlein, C., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28372 · Cited by 41
Echocardiographic Assessment of Functional Mitral Regurgitation: Opening Pandora's Box?
Hagendorff, A., Doenst, T., & Falk, V. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12491 · Cited by 41
“While the MITRA-FR investigators did not observe an effect on death and hospitalization within 12 month follow-up,(1) the COAPT investigators documented a 29% reduction of death and a 46% reduction of hospitalization within a 24 month follow-up.(2) These conflicting results gave rise to intensive discussions about ass…”
ResultHaberman, D., Taramasso, M., Czarnecki, A., Kerner, A., Chrissoheris, M. P., Spargias, K. S., Poles, L., Agmon, Y., Scianna, S. R., Beeri, R., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1565 · Cited by 41
Stolz, L., Doldi, P. M., Kresoja, K., Bombace, S., Koell, B., Kassar, M., Kirchner, J., Weckbach, L. T., Ludwig, S., Stocker, T. J., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.11.014 · Cited by 41
New Approaches to Assessment and Management of Tricuspid Regurgitation Before Intervention
Welle, G. A., Hahn, R. T., Lindenfeld, J. M., Lin, G., Nkomo, V. T., Hausleiter, J., Lurz, P. C., Pislaru, S. V., Davidson, C. J., & Eleid, M. F. (2024) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2024.02.034 · Cited by 40
Self-citationThe Choice of Treatment in Ischemic Mitral Regurgitation With Reduced Left Ventricular Function
Nappi, F., Singh, S., Padala, M., Attias, D., Nejjari, M., Mihos, C. G., Benedetto, U., & Michler, R. E. (2019) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2019.06.039 · Cited by 40
Transcatheter mitral valve replacement: factors associated with screening success and failure
Coisne, A., Pontana, F., Tchétché, D., Richardson, M., Longère, B., Vahdat, O., Berthoumieu, P., BELLE, E. V., Rousse, N., Lancellotti, P., et al. (2019) · EuroIntervention · doi:10.4244/eij-d-19-00444 · Cited by 40
Bedogni, F., Testa, L., Rubbio, A. P., Bianchi, G., Grasso, C., Scandura, S., MARCO, F. D., Tusa, M. B., Denti, P., Alfieri, O., et al. (2020) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2020.01.002 · Cited by 40
Kong, F., Caballero, A., McKay, R. G., & Sun, W. (2020) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2020.109730 · Cited by 40
Reappraisal on pharmacological and mechanical treatments of heart failure
Liang, B., Zhao, Y.-X., Zhang, X., Liao, H.-L., & Gu, N. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01024-5 · Cited by 40
“[151] AF ENGAGE AF-TIMI 48 [154] , HF-ACTION [155] , PARADIGM-HF/ATMOSPHERE [156] , TOPCAT [157] , ARISTOTLE [158] , AATAC [159] , CASTLE-AF [160] , GENETIC-AF [163] MR MITRA-FR [165, 166] , COAPT [167] Hyperkalemia Patiromer: PEARL-HF [170] , AMETHYST-DN [171] , Patiromer-204 [172] Lokelma: Stephen et al.”
BackgroundAcute Kidney Injury After Percutaneous Edge-to-Edge Mitral Repair
Armijo, G., Estévez‐Loureiro, R., Carrasco‐Chinchilla, F., Arzamendi, D., Fernández‐Vázquez, F., Jiménez‐Quevedo, P., Freixa, X., Pascual, I., Serrador, A., Mesa, D., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.582 · Cited by 40
“Among them, percutaneous mitral valve repair (PMVr) edge-to-edge with MitraClip (Abbott Vascular, Santa Clara, California) stands out because of its favorable results in functional MR (8).”
BackgroundTrends in Transcatheter vs Surgical Mitral Valve Repair Among Medicare Beneficiaries, 2012 to 2019
Young, M. N., Kearing, S. A., Albaghdadi, M. A., Latib, A., & Iribarne, A. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.0775 · Cited by 40
Müllens, W., Dauw, J., Gustafsson, F., Mebazaa, A., Steffel, J., Witte, K. K., Delgado, V., Linde, C. M., Vernooy, K., Anker, S. D., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3150 · Cited by 39
Burgess, S. N., Zaman, S. J., Towns, C. R., Coylewright, M. J., & Cader, F. A. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.12.011 · Cited by 39
Tabata, N., Weber, M., Sugiura, A., Öztürk, C., Ishii, M., Tsujita, K., Nickenig, G., & Sinning, J. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.09.014 · Cited by 39
CT for Pre- and Postprocedural Evaluation of Transcatheter Mitral Valve Replacement
Ranganath, P., Moore, A., Guerrero, M. E., Collins, J. D., Foley, T. A., Williamson, E. E., & Rajiah, P. S. (2020) · Radiographics · doi:10.1148/rg.2020200027 · Cited by 39
Management and Outcome of Failed Percutaneous Edge-to-Edge Mitral Valve Plasty
Mangieri, A., Melillo, F., Montalto, C., Denti, P., Praz, F., Sala, A., Winkel, M., Taramasso, M., Tagliari, A. P., Fam, N., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.11.040 · Cited by 39
Osteresch, R., Diehl, K., Kühl, M., Fiehn, E., Schmucker, J., Backhaus, T., Fach, A., Wienbergen, H., & Hambrecht, R. (2018) · Journal of Interventional Cardiology · doi:10.1111/joic.12566 · Cited by 38
Engineering Three-Dimensional Vascularized Cardiac Tissues
Williams, M. A. C., Mair, D. B., Lee, W., Lee, E., & Kim, D. (2022) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2020.0343 · Cited by 39
State-of-the-art intra-procedural imaging for the mitral and tricuspid PASCAL Repair System
Hahn, R. T., & Kodali, S. (2021) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab040 · Cited by 38
Okuno, T., Praz, F., Kassar, M., Biaggi, P., Mihalj, M., Külling, M., Widmer, S., Pilgrim, T., Grünenfelder, J., Kadner, A., et al. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.07.029 · Cited by 38
Medical Therapy for Functional Mitral Regurgitation
Milwidsky, A., Mathai, S. V., Topilsky, Y., & Jorde, U. P. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.122.009689 · Cited by 38
Early Outcomes of 2 Mitral Valve Transcatheter Leaflet Approximation Devices
Mauri, V., Sugiura, A., Spieker, M., Iliadis, C., Horn, P., Öztürk, C., Besler, C., Riebisch, M., Al‐Hammadi, O., Ruf, T. F., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.10.008 · Cited by 38
Spitzer, E., Hahn, R. T., Pîbarot, P., de Vries, T., Bax, J. J., Leon, M. B., & Mieghem, N. M. V. (2019) · Cardiac failure review · doi:10.15420/cfr.2018.41.2 · Cited by 38
“For instance, in the groundbreaking Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) trial, the chosen primary effectiveness endpoint was all hospitalisations for HF within 24 months of follow-up, including recurrent events…”
MethodMullens, W., & Martens, P. (2019) · Circulation · doi:10.1161/circulationaha.118.038135 · Cited by 36
“This, in addition to the lower EROA, is important to bear in mind when comparing this study with recent studies assessing the effect of MitraClip for secondary severe MR (see Figure B).(9,10) The primary end point of the study was the change in EROA from baseline to 12-month follow-up.”
ResultÁlvarez, A. B. C., Oriol Rodríguez-leor, C., Moreno, R., & de Prado, A. P. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.07.023 · Cited by 37
Atrial Functional Mitral Regurgitation Subtypes Undergoing Transcatheter Edge-to-Edge Repair
von Stein, P., von Stein, J., Hohmann, C., Wienemann, H., Guthoff, H., Körber, M. I., Baldus, S. E., Pfister, R., Hahn, R. T., & Iliadis, C. (2024) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2024.06.019 · Cited by 37
The year in cardiology: heart failure
Cleland, J. G. F., Lyon, A. R., McDonagh, T. A., & McMurray, J. J. V. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz949 · Cited by 37
Cardiopoietic Stem Cell Therapy in Ischaemic Heart Failure: Long-Term Clinical Outcomes
Bartúnek, J., Terzic, A., Davison, B. A., Behfar, A., y, R. S.-R., Wojakowski, W., Sherman, W., Heyndrickx, G. R., Metra, M., Filippatos, G. S., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13031 · Cited by 37
Mauri, V., Besler, C., Riebisch, M., Al‐Hammadi, O., Ruf, T. F., Gerçek, M., Horn, P., Grothusen, C., Mehr, M., Becher, M. U., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.08.025 · Cited by 37
Transcatheter mitral valve repair: an overview of current and future devices
Backer, O. D., Wong, I., Taramasso, M., Maisano, F., Franzen, O. W., & Søndergaard, L. (2021) · Open Heart · doi:10.1136/openhrt-2020-001564 · Cited by 37
Malagoli, A., Rossi, L. C., Zanni, A., Sticozzi, C., Piepoli, M. F., & Benfari, G. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2429 · Cited by 37
Parlow, S., Santo, P. D., Jung, R. G., Fam, N., Czarnecki, A., Horlick, E. M., Abdel‐Razek, O., Chan, V., Hynes, M., Nicholson, D., et al. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.08.008 · Cited by 37
Ludwig, S., Kalbacher, D., Ali, W. B., Weimann, J., Adam, M., Duncan, A., Webb, J. G., Windecker, S., Orban, M., Giannini, C., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2797 · Cited by 37
Cox, Z. L., ZALAWADIYA, S. K., Simonato, M., Redfors, B., Zhou, Z., Kotinkaduwa, L. N., Zile, M. R., Udelson, J. E., Lim, D. S., Grayburn, P. A., et al. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.03.009 · Cited by 37
Self-citationFlint, K. M., Brieke, A., Wiktor, D. M., & Carroll, J. D. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28089 · Cited by 37
“More recent data on pMVr in functional MR either excluded or did not focus on enrolling patients in shock.(5,6) Existing case reports and case series suggest that pMVr can be successful in patients with MR and shock.”
BackgroundMethodSelf-citationHealth Status Changes and Outcomes in Patients With Heart Failure and Mitral Regurgitation
Arnold, S. V., Stone, G. W., Mack, M. J., Chhatriwalla, A. K., Austin, B. A., Zhang, Z., Ben‐Yehuda, O., Kar, S., Lim, D. S., Lindenfeld, J. M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.002 · Cited by 37
Self-citationAn Introduction to Economics with Emphasis on Innovation
Pol, E., & Carroll, P. (2006) · eCite Digital Repository (University of Tasmania) · Cited by 37
Grayburn, P. A., Sannino, A., & Packer, M. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.05.043 · Cited by 37
Self-citationMinimally invasive mitral valve surgery is associated with a low rate of complications
Kastengren, M., Svenarud, P. K., Ahlsson, A., & Dalén, M. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12974 · Cited by 36
Sample size formula for a win ratio endpoint
Yu, R., & Ganju, J. (2022) · Statistics in Medicine · doi:10.1002/sim.9297 · Cited by 36
Fortmeier, V., Lachmann, M., Körber, M. I., Unterhuber, M., von Scheidt, M., Rippen, E., Harmsen, G., Gerçek, M., Friedrichs, K. P., Roder, F., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.12.043 · Cited by 36
Ahmad, Y., Petrie, M. C., Jolicoeur, M. E., Madhavan, M. V., Velazquez, E. J., Moses, J. W., Lansky, A. J., & Stone, G. W. (2022) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2022.100020 · Cited by 36
“37 The COAPT trial should be considered emblematic for how a trial of an interventional approach appreciated the synergistic relationship between any potential intervention and background optimized guideline-directed medical therapy.”
BackgroundSelf-citationParry, M. J. E., Spall, H. G. C. V., Mullen, K., Mulvagh, S. L., Pacheco, C., Colella, T. J. F., Clavel, M.-A. A., Jaffer, S., Foulds, H. J. A., Grewal, J., et al. (2022) · CJC Open · doi:10.1016/j.cjco.2022.04.002 · Cited by 36
Guía ESC 2021 sobre estimulación cardiaca y terapia de resincronización
Glikson, M., Nielsen, J. C., Kronborg, M. B., Michowitz, Y., Auricchio, A., Barbash, I. M., Barrabés, J. A., Boriani, G., Braunschweig, F., Brignole, M., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.025 · Cited by 37
Mitral Valve Transcatheter Edge-to-Edge Repair Using MitraClip or PASCAL
Schneider, L. M., Markovic, S., Mueller, K., Felbel, D., Gerçek, M., Friedrichs, K. P., Stolz, L., Rudolph, V., Hausleiter, J., Rottbauer, W., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.10.028 · Cited by 36
Acute Reduction in Left Ventricular Function Following Transcatheter Mitral Edge‐to‐Edge Repair
Perl, L., Kheifets, M., Ascione, G., Agricola, E., Denti, P., Wild, M. G., Praz, F., Rubbio, A. P., Bedogni, F., MARCO, F. D., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029735 · Cited by 36
Why Did COAPT Win While MITRA-FR Failed? Defining the Appropriate Patient Population for MitraClip
Atianzar, K., Zhang, M., Newhart, Z., & Gafoor, S. A. (2019) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2018.40.1 · Cited by 36
“Prospective clinical trials with hard clinical outcomes on the beneficial effect on secondary MR of enhancing GDMT with percutaneous transcatheter mitral valve repair had not been shown until now.(7)”
BackgroundMethodBuilding a Heart Failure Clinic: A Practical Guide from the Heart Failure Society of America
Greene, S. J., Adusumalli, S., Albert, N. M., Hauptman, P. J., Rich, M. W., Heidenreich, P. A., & Butler, J. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.10.008 · Cited by 36
Kato, N., Padang, R., Pislaru, C., Miranda, W. R., Hoshina, M., Shibayama, K., Watanabe, H., Scott, C. G., Greason, K. L., Pislaru, S. V., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040679 · Cited by 35
Impact of mitral regurgitation aetiology on MitraClip outcomes: the MitraSwiss registry
Sürder, D., Klersy, C., Corti, R., Biasco, L., Gaemperli, O., Maisano, F., Toggweiler, S., Jeger, R. V., Naegeli, B., Noble, S., et al. (2020) · EuroIntervention · doi:10.4244/eij-d-19-00718 · Cited by 35
Iliadis, C., Metze, C., Körber, M. I., Baldus, S. E., & Pfister, R. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.05.061 · Cited by 35
Right-to-Left Shunt Through Iatrogenic Atrial Septal Defect After MitraClip Procedure
Morikawa, T., Miyasaka, M., Flint, N., Manabe, O., Dawkins, S., Cheng, R., Hussaini, A., Makar, M. M., Kar, S., & Nakamura, M. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.03.056 · Cited by 35
Self-citationManagement of Heart Failure With Reduced Ejection Fraction
Rashid, A. M., Khan, M. S., Fudim, M., DeWald, T. A., DeVore, A. D., & Butler, J. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101596 · Cited by 35
Common Co-Morbidities in Heart Failure – Diabetes, Functional Mitral Regurgitation and Sleep Apnoea
Coats, A. J. S. (2019) · International Journal of Heart Failure · doi:10.36628/ijhf.2019.0004 · Cited by 35
Heart failure in dilated non-ischaemic cardiomyopathy
Seferovic, P. M., Polovina, M. M., & Coats, A. J. S. (2019) · European Heart Journal Supplements · doi:10.1093/eurheartj/suz212 · Cited by 35
“Therefore, echocardiographic monitoring and surgical or interventional treatment for severe mitral regurgitation may be considered in selected patients.(16) Occurrence of atrial fibrillation, even when asymptomatic, may cause severe deterioration of functional status and increase the risk of stroke andmortality.”
BackgroundIliadis, C., Baldus, S. E., Kalbacher, D., Boekstegers, P., Schillinger, W., Ouarrak, T., Zahn, R., Butter, C., Zuern, C. S., von Bardeleben, R. S., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1820 · Cited by 34
Alperi, A., Dagenais, F., del Val, D., Bernier, M., Vahl, T. P., Khalique, O. K., Modine, T., Granada, J. F., & Rodés‐Cabau, J. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.08.006 · Cited by 34
Kosmidou, I., Lindenfeld, J. M., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B. K., Kipperman, R., Boudoulas, K. D., Redfors, B., et al. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007293 · Cited by 35
Self-citationCharacteristics and Outcome of COAPT-Eligible Patients in the MITRA-FR Trial
Iung, B., Messika–Zeitoun, D., Boutitie, F., Trochu, J., Armoiry, X., Maucort‐Boulch, D., Obadia, J., & Vahanian, A. S. (2020) · Circulation · doi:10.1161/circulationaha.120.049743 · Cited by 34
Jain, S. S., Cohen, D. J., Zhang, Z., Uriel, N. Y., SAYER, G. T., Lindenfeld, J. M., Abraham, W. T., Mack, M. J., Stone, G. W., & Arnold, S. V. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007564 · Cited by 34
Self-citationLurz, P. C., Unterhuber, M., Rommel, K., Kresoja, K., Kister, T., Besler, C., Fengler, K., Sandri, M., Dähnert, I., Thiele, H., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.09.023 · Cited by 33
Consequences of canceling elective invasive cardiac procedures during Covid‐19 outbreak
Moreno, R., Gil, J. L. D., Diarte, J. A., Macaya, F., Hernández, J. D. L. T., Oriol Rodríguez-leor, C., Trillo, R., Alonso-Briales, J. H., Amat-Santos, I. J., Romaguera, R., et al. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29433 · Cited by 33
Diseases of the Cardiovascular System
Lockhart, P. B., & Sun, Y. (2021) · Wiley eBooks · doi:10.1002/9781119597797.ch14 · Cited by 32
Antithrombotic Treatment After Surgical and Transcatheter Heart Valve Repair and Replacement
Verstraete, A., Herregods, M. C., Verbrugghe, P., Lamberigts, M., Vanassche, T., Meyns, B. P., Oosterlinck, W., Rega, F., Adriaenssens, T., Hoof, L. V., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.702780 · Cited by 33
“The EVEREST II and the COAPT trial demonstrated the safety and efficacy of transcatheter mitral valve repair with MitraClip in wellselected patients with moderate or severe mitral regurgitation (54, 55).”
BackgroundMethodRight Side of the Heart Pulmonary Circulation Unit Involvement in Left-Sided Heart Failure
Marra, A. M., Sherman, A. E., Salzano, A., Guazzi, M., Saggar, R., Squire, I. B., Cittadini, A., Channick, R. N., & Bossone, E. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.09.023 · Cited by 33
Kataria, R., Castagna, F., Madan, S., Kim, P., Saeed, O., Adjepong, Y. A., Melainis, A. A., Taub, C., Garcia, M. J., Latib, A., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022908 · Cited by 33
Geis, N. A., Schlegel, P., Heckmann, M. B., Katus, H. A., Frey, N., López, P. C., & Raake, P. W. J. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13849 · Cited by 33
Hohmann, C., Ludwig, M., Walker, J., Iliadis, C., Schipper, J., Baldus, S. E., & Pfister, R. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-01988-2 · Cited by 33
Kandolin, R. M., Wiefels, C., Mesquita, C. T., Chong, A., Boland, P., Glineur, D., Sun, L. Y., Beanlands, R. S., & Mielniczuk, L. M. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.04.029 · Cited by 34
Messika–Zeitoun, D., Candolfi, P., Enriquez-Sarano, M. L., Burwash, I. G., Chan, V., Philippon, J.-F., Toussaint, J.-M., Verta, P., Feldman, T. E., Iung, B., et al. (2020) · Open Heart · doi:10.1136/openhrt-2020-001339 · Cited by 33
Hahn, R. T. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2019.6235 · Cited by 33
Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure
Lindman, B. R., Asch, F. M., Grayburn, P. A., Mack, M. J., Bax, J. J., Gonzales, H. M., Goel, K., Barker, C. M., ZALAWADIYA, S. K., Zhou, Z., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.02.031 · Cited by 32
Self-citationKitamura, M., Kresoja, K., Balata, M., Besler, C., Rommel, K., Unterhuber, M., Lurz, J. A., Rosch, S., Gunold, H., Noack, T., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.09.021 · Cited by 32
Metadata
- Authors
- Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., Rajagopal, V., Sarembock, I. J., Brieke, A., Marx, S. O., Cohen, D. J., Weissman, N. J., & Mack, M. J.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Cedars-Sinai Medical Center (US)
- Cleveland Clinic (US)
- University of Colorado Hospital (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-12-13
- Volume
- 379
- Issue
- 24
- Pages
- 2307-2318
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2889688444
- Cited by
- 3,017
- References
- 23
- Citations by year
- 2026: 253 · 2025: 330 · 2024: 308 · 2023: 372 · 2022: 385 · 2021: 486 · 2020: 453 · 2019: 376 · 2018: 42
- FWCI
- 256.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Abbott
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Surgery › Cardiac Structural Anomalies and Repair
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- transcatheter mitral valve repair, heart failure, functional mitral regurgitation, left ventricular dysfunction, heart failure hospitalization, all-cause mortality, device complications, guideline-directed medical therapy, COAPT trial, transcatheter edge-to-edge repair, mitral valve repair, transcatheter closure devices, transcatheter aortic valve implantation, transcatheter mitral valve replacement
- MeSH terms
- Aged, Aged, 80 and over, Combined Modality Therapy, Female, Heart Failure, Heart Valve Prosthesis, Hospitalization, Humans, Male, Middle Aged, Mitral Valve, Mitral Valve Insufficiency, Prosthesis Failure, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left, Heart Valve Prosthesis Implantation, Kaplan-Meier Estimate, Intention to Treat Analysis, Percutaneous Coronary Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.